Blogging Equity Research San Diego 
Xconomy
DECEMBER 7, 2018
Henrietta Lacks’ “immortal cells” contributed enormously to the progression of scientific discovery, but Lacks, a poor, black woman who died from cervical cancer in 1951 months after her cells were harvested, never personally benefited from or consented to the medical research the HeLa cell line enabled.
Xconomy
JUNE 12, 2019
Academic researchers have long studied gender and racial disparities in STEM education, but they have not had widespread success in addressing these challenges. If students stumble in these initial classes, research from the Association of American Universities. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
DECEMBER 2, 2019
Neurocrine Biosciences is paying $30 million cash and taking a $20 million equity stake in Xenon Pharmaceuticals to license a clinical-stage epilepsy drug and collaborate on other potential treatments for the seizure-causing brain disorder.
Xconomy
NOVEMBER 13, 2018
GreatCall, the maker of the Jitterbug cellphone and other products and services for older adults, has extended its partnership with the San Francisco-based ride-hailing company Lyft to offer GreatCall customers the ability to schedule rides without a smartphone app. No financial terms were disclosed.
socalTECH
DECEMBER 26, 2018
In my new role as the first executive director for the Alliance for Southern California Innovation, I spent a lot of time outside of my home turf of Pasadena -- visiting innovation nodes such as San Diego, Irvine, Riverside, Santa Barbara, Venice, Santa Monica, and others.
Xconomy
OCTOBER 1, 2019
Biologists have been using artificially created DNA, produced through what’s known as chemical DNA synthesis, as a research tool for decades. Now, as demand for engineered DNA rises, a handful of startups are vying to become the go-to provider for researchers looking for improved versions of the DNA sequences.
Xconomy
JANUARY 7, 2020
Eventually Celgene kicked in $35 million more for a research collaboration, an equity stake, and an exclusive option to acquire the startup, PharmAkea Therapeutics.
Expert insights. Personalized for you.
93 
Let's personalize your content